December 08, 2025 08:20 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Race against time! Indian Navy sends four more warships to Cyclone Ditwah-hit Sri Lanka | $2 billion mega deal! HD Hyundai to build shipyard in Tamil Nadu — a game changer for India | After 8 years of legal drama, Malayalam actor Dileep acquitted in 2017 rape case — what really happened? | Centre imposes temporary fare caps as ticket prices defy gravity amid IndiGo meltdown | 'Action is coming': Aviation Minister blames IndiGo for countrywide air travel chaos | In front of Putin, PM Modi makes bold statement on Russia-Ukraine war: ‘India is not neutral, we side with peace!’ | Rupee weakens following RBI repo rate cut | RBI slashes repo rate by 25 basis points — big relief coming for borrowers! | 'Mamata fooled Muslims': Humayun Kabir explodes after TMC suspends him over 'Babri Masjid-style mosque' demand; announces new party | Mosque in the middle of Kolkata airport? Centre confirms flight risks, BJP fires at Mamata

Donald Trump announces new COVID-19 vaccine efforts

| @indiablooms | May 16, 2020, at 01:35 pm

Washington/Xinhua/UNI: US President Donald Trump announced on Friday two men will lead his administration's new effort for COVID-19 vaccine development.

Former pharmaceutical executive Moncef Slaoui and Army General Gustave Perna, the commander of United States Army Materiel Command, will lead "Operation Warp Speed," the new project to accelerate the vaccine development process for COVID-19.

The new project is a "historic partnership" of federal agencies, Trump told a noon briefing in the White House Rose Garden.

He said experts throughout the government have been evaluating 100 vaccine candidates. Among them, 14 vaccine candidates are showing promise.

Trump said he is hopeful a COVID-19 vaccine can be developed by the end of the year.

"Typically pharmaceutical companies wait to manufacture a vaccine until it has received all the regulatory approvals necessary, and this can delay the vaccine's availability to the public as much as a year, even more than that," Trump said.

The federal government will invest in manufacturing all of the top vaccine candidates before they are approved, according to Trump.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine, and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020," said Slaoui, former chair of the vaccines division at pharmaceutical GlaxoSmithKline, a British multinational pharmaceutical company headquartered in London.

He said that in addition to a vaccine, the new project will also focus on the development of medicines for those COVID-19 infected, as well as improving and "optimizing" diagnostic tests. 

Image: Pixabay

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.